Ranbaxy’s JVC adjudged Malaysian Pharmaceutical Company of the Year for 2012

Ranbaxy Malaysia Sdn. Bhd., Malaysia, a joint venture company (JVC) of Ranbaxy Laboratories, has received the 2012 Frost & Sullivan Malaysia Excellence Award for being adjudged the Malaysian Pharmaceutical Company of the Year in the Generics Drug Category. The methodology and selection process involved a rigorous independent market research by Frost & Sullivian and evaluation by a distinguished panel of independent judges.

The 2012 Frost & Sullivan Malaysia Excellence Award was conferred to Ranbaxy Malaysia at a ceremony held in Kuala Lumpur on April 12, 2012.

Ranbaxy Malaysia Sdn Bhd (RMSB) is a joint venture company of Ranbaxy Laboratories, India and Malaysian shareholders. Established in 1984, RMSB is today one of the major generic companies in this market providing medicines in the Cardiovascular, CNS, Anti-infective, Gastroenterology and Anti-viral therapeutic segments.

Ranbaxy Laboratories, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.